Transverse medical appoints former boston scientific evp and global chief medical officer, professor ian t. meredith, to board of directors

Denver--(business wire)-- #cerebralembolicprotection--transverse medical, inc., developer of the point-guard™ cerebral embolic protection medical device, is pleased to announce the appointment of ian t. meredith, md to the board of directors. professor meredith brings over 35 years of experience and global leadership in cardiology coupled with successful clinical trials and device commercialization of multiple interventional devices. professor ian meredith, md has agreed to join the company's board of directors as an indep.
BSX Ratings Summary
BSX Quant Ranking